Dr. Dan P. Zandberg

John M. Kirkwood, MD, is a professor of medicine, dermatology, and clinical and translational science at the University of Pittsburgh School of Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh. Dr. Kirkwood directs the Melanoma Center at UPMC Hillman Cancer Center and specializes in melanoma research and the prevention and early detection of melanoma, as well as the treatment of advanced disease and adjuvant therapy of resectable disease. Dr. Kirkwood is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma.

Rahim A. Remtulla, MD, FACP, is a medical oncologist at UPMC Hillman Cancer Center. Dr. Remtulla specializes in the evaluation and treatment of all generalized oncology cases, various hematologic malignancies ; including chronic leukemia, multiple myeloma, lymphomas ; and benign hematologic conditions. Dr. Remtulla is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Pulmonary Embolism, Thrombocytopenia, Pleuropulmonary Blastoma, and Lung Cancer.

Zahra Rahman Kelly, DO, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Kelly is trained in the management of all cancers and blood disorders with a focus in genitourinary and head and neck malignancies.  Dr. Kelly is board-certified in nternal medicine and medical oncology and hematology. She received her medical degree from Philadelphia College of Osteopathic Medicine. Dr. Kelly completed both a residency in internal medicine and a fellowship in hematology/oncology at UPMC. She served as chief fellow during her final year of hematology/oncology fellowship. Her research interests include early phase clinical trial design and cancer immunotherapy combination trials. She has published papers in peer reviewed journals and is an active member of the UPMC Hillman protocol review committee where she reviews therapeutic oncology trials. She also collaborates with surgical oncologists and radiation oncologists to provide multidisciplinary care to her patients. Dr. Kelly is a member of the European Society of Medical Oncology, American Society of Medical Oncology, American Medical Association, and American Society of Hematology. Dr. Kelly is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. Her top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Febrile Neutropenia, Chronic Familial Neutropenia, and Gamma Knife Radiosurgery.